Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a ...

2) Genetics: Due to related susceptibility factors, those with a family history of kidney disease are more likely to develop ...

Among these, chronic kidney disease (CKD) and type 2 diabetes stand out for their severe ... while the other half were given a placebo over 24 weeks. Related Stories ・One third of normal-weight ...

Higher sKlotho levels are linked to lower CKD prevalence in individuals with diabetes and hypertension, but not in those without hypertension. The study suggests a synergistic effect between low ...

or death from kidney-related or CV causes). This is really one of the first trials that has shown convincing mortality benefits with any therapy in a target population of CKD and type 2 diabetes.

Please provide your email address to receive an email when new articles are posted on . Patients with a family history of diabetes had a threefold higher risk for diabetes-related comorbidities.

Jan. 29, 2025 -- The FDA has approved Novo Nordisk's diabetes drug Ozempic to help reduce the risk of worsening kidney disease, kidney failure, and heart-related death in adults with type 2 ...

The ESKD subset carries the highest risk of inpatient complications and related procedures. CKD is a risk factor for foot lesions in the diabetic population due to a high prevalence of concomitant ...

Patients with CKD and end-stage renal disease due to type 2 diabetes are also prone to complications such as hypoglycemia (low blood sugar), infections, or cardiovascular events.Managing these ...

Patients with diabetes and chronic kidney disease receiving physiologic insulin ... funds from Humana on a per-member per-month basis related to the patients’ risk scores as determined by ...